247 related articles for article (PubMed ID: 14725821)
1. Augmentation and tolerance with long-term pramipexole treatment of restless legs syndrome (RLS).
Winkelman JW; Johnston L
Sleep Med; 2004 Jan; 5(1):9-14. PubMed ID: 14725821
[TBL] [Abstract][Full Text] [Related]
2. Pramipexole in the management of restless legs syndrome: an extended study.
Silber MH; Girish M; Izurieta R
Sleep; 2003 Nov; 26(7):819-21. PubMed ID: 14655914
[TBL] [Abstract][Full Text] [Related]
3. Pramipexole in the treatment of restless legs syndrome: a follow-up study.
Montplaisir J; Denesle R; Petit D
Eur J Neurol; 2000 May; 7 Suppl 1():27-31. PubMed ID: 11054156
[TBL] [Abstract][Full Text] [Related]
4. Low-dose pramipexole in the management of restless legs syndrome. An open label trial.
Stiasny-Kolster K; Oertel WH
Neuropsychobiology; 2004; 50(1):65-70. PubMed ID: 15179023
[TBL] [Abstract][Full Text] [Related]
5. Encouraging initial response of restless legs syndrome to pramipexole.
Becker PM; Ondo W; Sharon D
Neurology; 1998 Oct; 51(4):1221-3. PubMed ID: 9781569
[TBL] [Abstract][Full Text] [Related]
6. Augmentation in patients with restless legs syndrome receiving pramipexole therapy: a retrospective study in a single center from China.
Wang T; Ying M; Zhao R; Zhu D; Zhang L
Sleep Breath; 2022 Mar; 26(1):373-380. PubMed ID: 33864178
[TBL] [Abstract][Full Text] [Related]
7. Comparison of pregabalin with pramipexole for restless legs syndrome.
Allen RP; Chen C; Garcia-Borreguero D; Polo O; DuBrava S; Miceli J; Knapp L; Winkelman JW
N Engl J Med; 2014 Feb; 370(7):621-31. PubMed ID: 24521108
[TBL] [Abstract][Full Text] [Related]
8. Polysomnographic record and successful management of augmentation in restless legs syndrome/Willis-Ekbom disease.
Maestri M; Fulda S; Ferini-Strambi L; Zucconi M; Marelli S; Staedler C; Bassetti CL; Manconi M
Sleep Med; 2014 May; 15(5):570-5. PubMed ID: 24767724
[TBL] [Abstract][Full Text] [Related]
9. A method to switch from oral dopamine agonists to rotigotine in patients with restless legs syndrome and mild augmentation.
Winkelman JW; Mackie SE; Mei LA; Platt S; Schoerning L
Sleep Med; 2016 Aug; 24():18-23. PubMed ID: 27810181
[TBL] [Abstract][Full Text] [Related]
10. Identification and treatment of augmentation in patients with restless legs syndrome: practical recommendations.
Geyer J; Bogan R
Postgrad Med; 2017 Sep; 129(7):667-675. PubMed ID: 28818004
[TBL] [Abstract][Full Text] [Related]
11. Long-term use of pramipexole in the management of restless legs syndrome.
Lipford MC; Silber MH
Sleep Med; 2012 Dec; 13(10):1280-5. PubMed ID: 23036265
[TBL] [Abstract][Full Text] [Related]
12. Factors affecting the efficacy of pramipexole in patients with restless legs syndrome.
Rezvani M; Zamani B; Fereshtehnejad SM
Acta Med Iran; 2013 Jul; 51(6):377-85. PubMed ID: 23852842
[TBL] [Abstract][Full Text] [Related]
13. Newer dopamine agonists in the treatment of restless legs syndrome.
Weimerskirch PR; Ernst ME
Ann Pharmacother; 2001 May; 35(5):627-30. PubMed ID: 11346069
[TBL] [Abstract][Full Text] [Related]
14. First night efficacy of pramipexole in restless legs syndrome and periodic leg movements.
Manconi M; Ferri R; Zucconi M; Oldani A; Fantini ML; Castronovo V; Ferini-Strambi L
Sleep Med; 2007 Aug; 8(5):491-7. PubMed ID: 17512780
[TBL] [Abstract][Full Text] [Related]
15. The acute effect of a low dosage of pramipexole on severe idiopathic restless legs syndrome: an open-label trial.
Merlino G; Dolso P; Canesin R; Cancelli I; Valente M; Gigli GL
Neuropsychobiology; 2006; 54(3):195-200. PubMed ID: 17314491
[TBL] [Abstract][Full Text] [Related]
16. Restless legs syndrome: differential diagnosis and management with pramipexole.
Brindani F; Vitetta F; Gemignani F
Clin Interv Aging; 2009; 4():305-13. PubMed ID: 19750232
[TBL] [Abstract][Full Text] [Related]
17. Restless legs syndrome augmentation among Japanese patients receiving pramipexole therapy: Rate and risk factors in a retrospective study.
Takahashi M; Nishida S; Nakamura M; Kobayashi M; Matsui K; Ito E; Usui A; Inoue Y
PLoS One; 2017; 12(3):e0173535. PubMed ID: 28264052
[TBL] [Abstract][Full Text] [Related]
18. Long-term treatment of restless legs syndrome with dopamine agonists.
Ondo W; Romanyshyn J; Vuong KD; Lai D
Arch Neurol; 2004 Sep; 61(9):1393-7. PubMed ID: 15364685
[TBL] [Abstract][Full Text] [Related]
19. Long-term open-label study of pramipexole in patients with primary restless legs syndrome.
Inoue Y; Kuroda K; Hirata K; Uchimura N; Kagimura T; Shimizu T
J Neurol Sci; 2010 Jul; 294(1-2):62-6. PubMed ID: 20451927
[TBL] [Abstract][Full Text] [Related]
20. High national rates of high-dose dopamine agonist prescribing for restless legs syndrome.
Winkelman JW
Sleep; 2022 Feb; 45(2):. PubMed ID: 34417810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]